Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS30027259HIVENSG00000183049.14protein_codingCAMK1DNoNo57118Q5SQQ7
Q8IU85
TVIS20009544HPVENSG00000183049.14protein_codingCAMK1DNoNo57118Q5SQQ7
Q8IU85
TVIS20012755HPVENSG00000183049.14protein_codingCAMK1DNoNo57118Q5SQQ7
Q8IU85
TVIS20049164HPVENSG00000183049.14protein_codingCAMK1DNoNo57118Q5SQQ7
Q8IU85
TVIS20033270HPVENSG00000183049.14protein_codingCAMK1DNoNo57118Q5SQQ7
Q8IU85
TVIS20046701HPVENSG00000183049.14protein_codingCAMK1DNoNo57118Q5SQQ7
Q8IU85
TVIS20027478HPVENSG00000183049.14protein_codingCAMK1DNoNo57118Q5SQQ7
Q8IU85
TVIS20025447HPVENSG00000183049.14protein_codingCAMK1DNoNo57118Q5SQQ7
Q8IU85
TVIS20014037HPVENSG00000183049.14protein_codingCAMK1DNoNo57118Q5SQQ7
Q8IU85
TVIS20044417HPVENSG00000183049.14protein_codingCAMK1DNoNo57118Q5SQQ7
Q8IU85
TCGA Plot Options
Drug Information
GeneCAMK1D
DrugBank IDDB12010
Drug NameFostamatinib
Target IDBE0004324
UniProt IDQ8IU85
Regulation Typeinhibitor
PubMed IDs26516587
CitationsRolf MG, Curwen JO, Veldman-Jones M, Eberlein C, Wang J, Harmer A, Hellawell CJ, Braddock M: In vitro pharmacological profiling of R406 identifies molecular targets underlying the clinical effects of fostamatinib. Pharmacol Res Perspect. 2015 Oct;3(5):e00175. doi: 10.1002/prp2.175. Epub 2015 Sep 4.
GroupsApproved; Investigational
Direct ClassificationMethoxyanilines
SMILESCOC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Pathways
PharmGKB
ChEMBLCHEMBL2103830